245 related articles for article (PubMed ID: 27124472)
1. Behavioral Abnormalities in a Mouse Model of Chronic Toxoplasmosis Are Associated with MAG1 Antibody Levels and Cyst Burden.
Xiao J; Li Y; Prandovszky E; Kannan G; Viscidi RP; Pletnikov MV; Yolken RH
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004674. PubMed ID: 27124472
[TBL] [Abstract][Full Text] [Related]
2. Chronic Toxoplasma gondii Infection Induces Anti-
Li Y; Viscidi RP; Kannan G; McFarland R; Pletnikov MV; Severance EG; Yolken RH; Xiao J
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037790
[TBL] [Abstract][Full Text] [Related]
3. [Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].
Fond G; Capdevielle D; Macgregor A; Attal J; Larue A; Brittner M; Ducasse D; Boulenger JP
Encephale; 2013 Feb; 39(1):38-43. PubMed ID: 23095600
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts.
Nielsen HV; Di Cristina M; Beghetto E; Spadoni A; Petersen E; Gargano N
Exp Parasitol; 2006 Apr; 112(4):274-9. PubMed ID: 16368092
[TBL] [Abstract][Full Text] [Related]
5. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.
Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ
Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
[TBL] [Abstract][Full Text] [Related]
7. Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector.
Tomita T; Mukhopadhyay D; Han B; Yakubu R; Tu V; Mayoral J; Sugi T; Ma Y; Saeij JPJ; Weiss LM
mBio; 2021 May; 12(3):. PubMed ID: 34006649
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts.
Parmley S; Slifer T; Araujo F
J Infect Dis; 2002 Feb; 185 Suppl 1():S90-5. PubMed ID: 11865445
[TBL] [Abstract][Full Text] [Related]
10. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection.
Di Cristina M; Del Porto P; Buffolano W; Beghetto E; Spadoni A; Guglietta S; Piccolella E; Felici F; Gargano N
Microbes Infect; 2004 Feb; 6(2):164-71. PubMed ID: 14998514
[TBL] [Abstract][Full Text] [Related]
11. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis.
Berenreiterová M; Flegr J; Kuběna AA; Němec P
PLoS One; 2011; 6(12):e28925. PubMed ID: 22194951
[TBL] [Abstract][Full Text] [Related]
12. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
[TBL] [Abstract][Full Text] [Related]
13. Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate.
Djurković-Djaković O; Nikolić A; Bobić B; Klun I; Aleksić A
Microbes Infect; 2005 Jan; 7(1):49-54. PubMed ID: 15716077
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of variation in Toxoplasma gondii cyst burden in the murine model.
Watson GF; Davis PH
Exp Parasitol; 2019 Jan; 196():55-62. PubMed ID: 30562481
[TBL] [Abstract][Full Text] [Related]
16. [Kinetic distribution of cyst-forming Chinese isolate of Toxoplasma gondii in mice].
Wang L; Huo XX; Chen ZW; Chen H; Yu L; Song XR; Faustina HL; Luo QL; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):179-83. PubMed ID: 23072130
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
18. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite.
Araujo F; Slifer T; Kim S
J Parasitol; 1997 Jun; 83(3):521-2. PubMed ID: 9194838
[TBL] [Abstract][Full Text] [Related]
19. Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans.
Holec L; Hiszczyńska-Sawicka E; Gasior A; Brillowska-Dabrowska A; Kur J
Clin Vaccine Immunol; 2007 Mar; 14(3):220-5. PubMed ID: 17202305
[TBL] [Abstract][Full Text] [Related]
20. Guanabenz Reverses a Key Behavioral Change Caused by Latent Toxoplasmosis in Mice by Reducing Neuroinflammation.
Martynowicz J; Augusto L; Wek RC; Boehm SL; Sullivan WJ
mBio; 2019 Apr; 10(2):. PubMed ID: 31040237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
